The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 96,850 | 630,000 | SH | OTR | 630,000 | 0 | 0 | ||
| BELLEROPHON THERAPEUTICS INC | COM | 078771102 | 4,494 | 1,857,143 | SH | OTR | 1,857,143 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 28,101 | 2,094,000 | SH | OTR | 2,094,000 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 20,544 | 1,065,000 | SH | OTR | 1,065,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 53,886 | 1,375,000 | SH | OTR | 1,375,000 | 0 | 0 | ||
| GTX INC DEL | COM NEW | 40052B207 | 20,056 | 1,310,000 | SH | OTR | 1,310,000 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 20,346 | 1,172,700 | SH | OTR | 1,172,700 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 15,375 | 844,789 | SH | OTR | 844,789 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 26,571 | 95,000 | SH | OTR | 87,500 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 25,709 | 1,245,000 | SH | OTR | 1,245,000 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 45,875 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
| MEI PHARMA INC | COM NEW | 55279B202 | 11,478 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 77,182 | 1,565,560 | SH | OTR | 1,565,560 | 0 | 0 | ||
| NOVUS THERAPEUTICS INC | COM | 67011N105 | 2,271 | 324,383 | SH | OTR | 324,383 | 0 | 0 | ||
| ODONATE THERAPEUTICS INC | COM | 676079106 | 62,419 | 2,826,938 | SH | OTR | 2,826,938 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 64,087 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 11,365 | 325,000 | SH | OTR | 325,000 | 0 | 0 | ||
| REGULUS THERAPEUTICS INC | COM | 75915K101 | 1,121 | 1,697,802 | SH | OTR | 1,697,802 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 6,571 | 2,321,900 | SH | OTR | 2,321,900 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 38,594 | 1,966,051 | SH | OTR | 1,966,051 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 49,568 | 375,000 | SH | OTR | 375,000 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM | 83422E105 | 99,051 | 2,780,000 | SH | OTR | 2,780,000 | 0 | 0 | ||
| SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 4,505 | 2,125,000 | SH | OTR | 2,125,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 702 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 35,588 | 3,750,000 | SH | OTR | 3,750,000 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 60,840 | 1,590,600 | SH | OTR | 1,590,600 | 0 | 0 | ||